No Data
No Data
Express News | Delta Plus: MidCap Partners Cuts Target Price to EUR 74 From EUR 78; Rating "Buy"
Further Weakness as Autolus Therapeutics (NASDAQ:AUTL) Drops 9.0% This Week, Taking Five-year Losses to 83%
European Equities Traded in the US as American Depositary Receipts Rise Thursday
Truist Financial Maintains Autolus Therapeutics(AUTL.US) With Buy Rating
Autolus Therapeutics (AUTL) Gets a Buy From Truist Financial
Express News | Autolus Therapeutics to Present Key Data on AUCATZYL At 2025 Tandem Meetings, Highlighting Cost Benefits and Clinical Outcomes
Unlock the Full List
blessings u : Thank you for sharing.
Trytosaveabit OP blessings u : you’re welcome![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)